(Q43432288)

English

Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients

scientific article published on 8 January 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Measurement of the uncomplexed fraction of tissue inhibitor of metalloproteinases-1 in the prognostic evaluation of primary breast cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

author name string

Sidse Ørnbjerg Würtz

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ib Jarle Christensen

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Anne-Sofie Schrohl

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Henning Mouridsen

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Ulrik Lademann

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Vibeke Jensen

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Nils Brünner

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

8 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Molecular & Cellular Proteomics

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

483-491

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Metalloproteinases and tissue inhibitors of metalloproteinases

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

A high serum matrix metalloproteinase-2 level is associated with an adverse prognosis in node-positive breast carcinoma

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

TIMPs as multifacial proteins

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Tumor tissue levels of tissue inhibitor of metalloproteinase-1 as a prognostic marker in primary breast cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Rescue of mammary epithelial cell apoptosis and entactin degradation by a tissue inhibitor of metalloproteinases-1 transgene

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Inhibition of endothelial cell migration by gene transfer of tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M400209-MCP200

21 January 2018

Identifiers

10.1074/MCP.M400209-MCP200

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43432288&oldid=1988791257"